Fasenra 00310-1745
Generic: Benralizumab
Product NDC
00310-1745- Manufacturer
- Astrazeneca Pharmaceuticals Lp
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- April 5, 2024
- Listing Expires
- December 31, 2027
- Application
- BLA761070
Need to source Fasenra? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Benralizumab | 10 mg/.5mL |
Drug Class
Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]Interleukin 5 Receptor alpha-directed Antibody Interactions [MoA]Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]
Packaging Options(2)
1 CARTRIDGE in 1 CARTON (0310-1745-01) / .5 mL in 1 CARTRIDGE
1 CARTRIDGE in 1 CARTON (0310-1745-95) / .5 mL in 1 CARTRIDGE